These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4905646)

  • 21. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dietary essential amino acid limitations upon the susceptibility to Salmonella typhimurium and the effect upon humoral and cellular immune responses in mice.
    Petro TM; Bhattacharjee JK
    Infect Immun; 1981 Apr; 32(1):251-9. PubMed ID: 7012029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of the protective antigen in Salmonella typhimurium.
    Mates A; Yosipovici H
    Microbios; 1976; 16(64):81-90. PubMed ID: 800632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic determinants of Salmonella for production of "clearance" factor in mouse typhoid.
    Nakano M; Saito K; Toyasaki N
    Jpn J Microbiol; 1970 Mar; 14(2):163-70. PubMed ID: 4910537
    [No Abstract]   [Full Text] [Related]  

  • 26. Intradermal vaccination against Salmonella typhimurium. Experimental study on mice.
    Dimache G; Gogulescu L; Tărbuc R; Dimache V
    Arch Roum Pathol Exp Microbiol; 1976 Jul; 35(3):265-8. PubMed ID: 798565
    [No Abstract]   [Full Text] [Related]  

  • 27. Proteins from Salmonella R-mutants mediating protection against Salmonella typhimurium infection in mice. III. Separation and purification of soluble proteins and their use as vaccines and as precipitating antigens.
    Bhatnagar N; Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Dec; 260(4):448-58. PubMed ID: 3914792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Salmonellosis: distribution of the causative organism in the body].
    Boĭchenko MN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):3-6. PubMed ID: 6151767
    [No Abstract]   [Full Text] [Related]  

  • 29. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R
    Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ribosomal vaccine obtained from Salmonella typhimurium and tested against the challenge of an orally administered virulent microorganism].
    Molinari JL; Gavilanes M; Tato P
    Arch Invest Med (Mex); 1976; 7(3):127-34. PubMed ID: 797331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental salmonellosis. Immunizing effect of live vaccine prepared from various mutants of Salmonella having different cell wall polysaccharides.
    Kawakami M; Nakata H; Mitsuhashi S
    Jpn J Microbiol; 1969 Dec; 13(4):315-24. PubMed ID: 4902129
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic manipulation of Salmonella serotype Bovismorbificans to aromatic-dependence and evaluation of its vaccine potential in mice.
    Mukkur TK; Stocker BA; Walker KH
    J Med Microbiol; 1991 Jan; 34(1):57-62. PubMed ID: 1990138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease.
    Rüssmann H
    Int J Med Microbiol; 2004 Apr; 293(7-8):565-9. PubMed ID: 15149032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
    Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
    Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms in antimicrobial immunity.
    Collins FM
    J Reticuloendothel Soc; 1971 Jul; 10(1):58-99. PubMed ID: 4941266
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of antibody on intracellular parasitism of Salmonella typhimurium in mononuclear phagocytes in vitro: prolonged survival of infected monocytes in presence of antibody.
    GELZER J; SUTER E
    J Exp Med; 1959 Nov; 110(5):715-30. PubMed ID: 13827241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salmonellosis in mice: immunization experiments with salmonella-escherichia coli hybrids.
    Kiefer W; Gransow P; Schmidt G; Westphal O
    Infect Immun; 1976 May; 13(5):1517-8. PubMed ID: 773838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible mechanism for host-specific pathogenesis of Salmonella serovars.
    Ishibashi Y; Arai T
    Microb Pathog; 1996 Dec; 21(6):435-46. PubMed ID: 8971684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of OmpL as a potential vaccine candidate for immune-protection against salmonellosis in mice.
    Yang Y; Wan C; Xu H; Wei H
    Vaccine; 2013 Jun; 31(28):2930-6. PubMed ID: 23643894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.